Full Text View
Tabular View
No Study Results Posted
Related Studies
An Investigation of the Effects of Erythromycin on the Pharmacokinetics of the Pregabalin Controlled Release Tablet
This study has been completed.
Study NCT01342198   Information provided by Pfizer

First Received on April 21, 2011.   Last Updated on July 27, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Healthy
Interventions listed in this trial
erythromycin
Additional drug interventions recognized in this trial
Erythromycin Estolate
Erythromycin Ethylsuccinate
Erythromycin stearate
Pregabalin
More general drug interventions related to this trial
Analgesics
Anti-Bacterial Agents
Anti-Infective Agents
Anticonvulsants
Central Nervous System Agents
Enzyme Inhibitors
Gastrointestinal Agents
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protein Synthesis Inhibitors
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services